This inventor holds 1 USPTO granted patent. Top assignee: Shenyang Pharmaceutical University. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovations of Jingli Wang in Cancer Treatment
Introduction
Jingli Wang is an accomplished inventor based in Shenyang, China. He has made significant contributions to the field of medicine, particularly in the development of innovative compounds for cancer treatment. His work focuses on creating effective therapeutic agents that can combat various types of cancer.
Latest Patents
Jingli Wang holds a patent for "2-methylene-5-substituted-methylenecyclopentanone derivatives and use thereof." This invention relates to derivatives that serve as active components in the preparation of medicines aimed at treating and preventing several cancer diseases, including breast cancer, lung cancer, colon cancer, and more. The active compounds can be utilized as standalone anticancer drugs or in combination with other antitumor medications, allowing for flexible treatment options.
Career Highlights
Jingli Wang is affiliated with Shenyang Pharmaceutical University, where he contributes to research and development in pharmaceutical sciences. His innovative approach to drug development has positioned him as a key figure in the fight against cancer.
Collaborations
Jingli Wang collaborates with notable colleagues, including Rui Wang and Linxiang Zhao, who share his commitment to advancing cancer treatment through innovative research.
Conclusion
Jingli Wang's contributions to cancer treatment through his patented inventions highlight the importance of innovation in medicine. His work not only showcases his expertise but also offers hope for improved therapeutic options for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile